KK
Kajal Kiran Damania
About Kajal Kiran Damania
Data last updated:
Kajal Kiran Damania is a Company Secretary at Sun Pharma Advanced Research Company Limited (since 2023), Director at Mvk Lifesciences Private Limited (since 2022) and Director at Apex Drugs Limited (since 2020). The companies operate in Pharma, Transport and Logistics and Food and Beverages. The largest current company by reported revenue is Sun Pharma Advanced Research Company Limited at ₹73.56 Cr (FY 2025). Earlier, Kajal Kiran Damania was a Director at Noma Infrastructure Private Limited (2024–2025) and Director at Phoenix Comtrade Private Limited (2019) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharma Advanced Research Company Limited L73100GJ2006PLC047837 | Company Secretary | 22 Sep 2023 | 2006 | ₹73.56 Cr (FY 2025) | Active |
 Mvk Lifesciences Private Limited U51397MH2021PTC369982 | Director | 01 Feb 2022 | 2021 | Active | |
 Apex Drugs Limited U24230TG1989PLC010737 | Director | 28 Aug 2020 | 1989 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Noma Infrastructure Private Limited U63000MH2014PTC252409 | Director | 01 Feb 2024 | 2014 | ₹216 Cr (FY 2025) | Active |
 Phoenix Comtrade Private Limited U52190MH2006PTC159622 | Director | 01 Jul 2019 | 2006 | ₹2.27 Cr (FY 2019) | Active |
 Reliance Broadcast Network Limited U64200MH2005PLC158355 | Company Secretary | 17 Feb 2022 | 2005 | ₹220 Cr (FY 2024) | Active |
| Apac Trade Private Limited U74999MH2013PTC245656 | Director | 23 Apr 2019 | 2013 | ₹488 Cr (FY 2023) | Active |
 Tag Offshore Limited U63090MH2003PLC139657 | Company Secretary | 21 Oct 2016 | 2003 | ₹236 Cr (FY 2018) | Under Liquidation |
 Cello Pens And Stationery Private Limited U36991DD1998PTC002614 | Company Secretary | 01 Apr 2013 | 1998 | ₹95.85 Cr (FY 2025) | Active |
 Cello Stationery Products Private Limited U25209MH2008PTC180662 | Company Secretary | 02 Apr 2012 | 2008 | ₹166 Cr (FY 2016) | Amalgamated |
 Repro India Limited L22200MH1993PLC071431 | Nodal Officer | 07 Oct 2017 | 1993 | ₹498 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kajal Kiran Damania
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar | Sun Pharma Advanced Research Company Limited | Ceo | |
| Anup Madanmohan Rathi | Sun Pharma Advanced Research Company Limited | Cfo | |
| Dilip Shantilal Shanghvi | 00005588 | Sun Pharma Advanced Research Company Limited | Director |
| Rajamannar Thennati | 01415412 | Sun Pharma Advanced Research Company Limited | Director |
| Rekha Gopal Warriar | 08152356 | Sun Pharma Advanced Research Company Limited | Director |
| Robert Jay Spiegel | 08739625 | Sun Pharma Advanced Research Company Limited | Director |
| Venkateswarlu Jasti | 00278028 | Sun Pharma Advanced Research Company Limited | Director |
| Vidhi Dilip Shanghvi | 06497350 | Sun Pharma Advanced Research Company Limited | Director |
| Gajanana Kudva | 08854872 | Mvk Lifesciences Private Limited , Apex Drugs Limited | Director |
| Shankar Sitaram Dige | Apex Drugs Limited | Cfo | |
| Shankar Sitaram Dige | 01853445 | Apex Drugs Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kajal Kiran Damania
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kajal Kiran Damania
Kajal Kiran Damania currently holds 3 directorships: Sun Pharma Advanced Research Company Limited (Company Secretary, since 22 Sep 2023, revenue ₹73.56 Cr (FY 2025)); Mvk Lifesciences Private Limited (Director, since 01 Feb 2022); Apex Drugs Limited (Director, since 28 Aug 2020).
Kajal Kiran Damania was first appointed on 02 Apr 2012 as Company Secretary at Cello Stationery Products Private Limited. The most recent appointment on record is 01 Feb 2024 at Noma Infrastructure Private Limited.
Kajal Kiran Damania held 8 earlier board appointments: Noma Infrastructure Private Limited (Director, 01 Feb 2024 to 01 Aug 2025); Phoenix Comtrade Private Limited (Director, 01 Jul 2019 to 26 Nov 2019); Reliance Broadcast Network Limited (Company Secretary, 17 Feb 2022 to 03 Oct 2023); Apac Trade Private Limited (Director, 23 Apr 2019 to 09 Aug 2023); Tag Offshore Limited (Company Secretary, 21 Oct 2016 to 23 Feb 2017); and 3 more.
The current boards of Kajal Kiran Damania's companies include Anil Kumar (Sun Pharma Advanced Research Company Limited), Anup Madanmohan Rathi (Sun Pharma Advanced Research Company Limited), Dilip Shantilal Shanghvi (Sun Pharma Advanced Research Company Limited), Rajamannar Thennati (Sun Pharma Advanced Research Company Limited), Rekha Gopal Warriar (Sun Pharma Advanced Research Company Limited), Robert Jay Spiegel (Sun Pharma Advanced Research Company Limited), among others.